Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Restructuring Costs: 2010-2011

Historic Restructuring Costs for Lexicon Pharmaceuticals (LXRX) over the last 1 years, with Dec 2011 value amounting to $1.6 million.

  • Lexicon Pharmaceuticals' Restructuring Costs rose 0.19% to $1.6 million in Q4 2011 from the same period last year, while for Dec 2011 it was $6.8 million, marking a year-over-year change of. This contributed to the annual value of $6.8 million for FY2011, which is 149.67% up from last year.
  • Per Lexicon Pharmaceuticals' latest filing, its Restructuring Costs stood at $1.6 million for Q4 2011, which was down 32.88% from $2.3 million recorded in Q3 2011.
  • In the past 5 years, Lexicon Pharmaceuticals' Restructuring Costs registered a high of $2.3 million during Q3 2011, and its lowest value of $1.1 million during Q1 2011.
  • For the 2-year period, Lexicon Pharmaceuticals' Restructuring Costs averaged around $1.6 million, with its median value being $1.6 million (2010).
  • Data for Lexicon Pharmaceuticals' Restructuring Costs shows a peak YoY surged of 104.02% (in 2011) over the last 5 years.
  • Quarterly analysis of 2 years shows Lexicon Pharmaceuticals' Restructuring Costs stood at $1.6 million in 2010, then rose by 0.19% to $1.6 million in 2011.
  • Its Restructuring Costs was $1.6 million in Q4 2011, compared to $2.3 million in Q3 2011 and $1.8 million in Q2 2011.